Anacor Pharma (ANAC) Tops Q1 EPS by 19c

Anacor Pharma (NASDAQ: ANAC) reported Q1 EPS of ($0.30), $0.19 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $15.26 million versus the consensus estimate of $9.2 million.

For earnings history and earnings-related data on Anacor Pharma (ANAC) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
• SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%